Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",40502,311,1.49 [1.24-1.77],1.285763146778758e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,40867,318,2.48 [1.72-3.59],1.2208854945724028e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,40997,319,1.92 [1.55-2.37],1.96880229336709e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,34825,269,1.67 [1.30-2.15],5.847055397607759e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40502,311,1.96 [1.42-2.70],4.722553358371559e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,41531,322,3.68 [2.89-4.69],7.289267134232985e-26
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,35707,278,1.88 [1.33-2.66],0.0003836619412347
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,35707,278,2.04 [1.70-2.45],9.346634993332276e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,41402,323,2.13 [1.53-2.97],7.786796574982453e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,41544,326,2.08 [1.61-2.69],2.0734844970756254e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,41742,327,2.37 [1.45-3.87],0.0005962663429188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,41611,321,1.58 [1.23-2.02],0.0002972040207774
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,41045,321,1.45 [1.22-1.73],2.697873182344292e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,34908,268,0.63 [0.49-0.82],0.0005154239392693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,41330,322,0.48 [0.34-0.68],2.596004303059275e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,35707,278,1.53 [1.22-1.91],0.0002618555378555
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,35912,278,1.65 [1.43-1.90],3.364109900496279e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",41402,323,2.34 [1.66-3.29],1.1956848415732202e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,40301,312,1.94 [1.45-2.61],9.568042267277329e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,35790,277,1.30 [1.15-1.48],3.406071019756378e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,35707,278,1.88 [1.70-2.08],3.423768876966372e-35
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,34825,269,1.85 [1.53-2.25],4.0241516589180504e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,41402,323,2.86 [2.05-3.97],4.4275407539740926e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,41195,324,1.89 [1.53-2.33],4.325324859603469e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,41501,325,3.60 [2.46-5.28],5.180721143052213e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,35845,278,4.29 [2.36-7.80],1.7752012657753695e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,35051,271,1.99 [1.38-2.88],0.0002420472105899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,35885,280,1.54 [1.23-1.92],0.0001380734758579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,41108,321,4.49 [2.78-7.24],8.229449722534853e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,41129,320,1.59 [1.30-1.95],9.655507669914042e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,41742,327,1.45 [1.18-1.79],0.0003775762940838
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,41402,323,1.58 [1.33-1.87],1.3435238288197977e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,40797,321,1.40 [1.17-1.67],0.0002137597383406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,41341,322,1.24 [1.10-1.39],0.0002836669342651
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,41195,324,1.37 [1.24-1.50],7.339280428079032e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,41275,322,1.23 [1.10-1.37],0.0003500079243576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,40399,318,1.53 [1.21-1.92],0.000299526241963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,41710,326,1.67 [1.37-2.03],2.979556156056064e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,41351,323,2.56 [1.69-3.88],9.044672196611302e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,41195,324,2.19 [1.57-3.07],4.847691553149172e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,41061,324,1.58 [1.21-2.07],0.0007832504619179
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,41710,326,3.24 [2.77-3.80],1.1547017001384836e-48
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,41351,323,3.71 [3.08-4.46],5.324283500789391e-44
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,40937,319,2.25 [1.80-2.81],1.1840518988411029e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,40301,312,2.41 [2.12-2.72],2.782318874343826e-43
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,35096,275,2.10 [1.46-3.04],7.304880848630709e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,41603,324,1.68 [1.28-2.21],0.0001892743731854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,41476,319,2.09 [1.68-2.60],3.3845720382031236e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,41611,321,1.64 [1.36-1.98],2.409285233692677e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,41045,321,1.87 [1.38-2.53],4.457217342578427e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,41121,324,1.74 [1.41-2.15],2.4361621890842764e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,41341,322,3.63 [2.66-4.94],3.372728458873297e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,41552,321,3.46 [2.88-4.16],3.3568947293693166e-40
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,35723,274,2.07 [1.65-2.61],5.619609934232142e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,41636,325,1.50 [1.25-1.81],1.6877604283842035e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,34759,269,2.03 [1.68-2.45],2.5973516158929015e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,41195,324,3.38 [2.84-4.03],1.5023976747677262e-42
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,35096,275,4.77 [3.96-5.75],1.8976583541115287e-60
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,41603,324,3.37 [2.65-4.27],1.6444746681594133e-23
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,41710,326,3.90 [3.40-4.47],2.3586534030365067e-85
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,35859,278,6.13 [5.01-7.50],1.5481359920554165e-69
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,41195,324,4.56 [3.63-5.74],1.9241582034780353e-38
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,35707,278,2.69 [1.88-3.87],7.32758954185818e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,40937,319,1.50 [1.26-1.78],3.444972465911354e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,41603,324,1.92 [1.50-2.45],1.8397635669641882e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,41195,324,1.34 [1.21-1.49],4.50836307041011e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,41331,326,0.80 [0.70-0.90],0.0004235922665246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,41045,321,0.70 [0.60-0.83],2.675842662757791e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",35790,277,1.79 [1.44-2.24],2.348361859458057e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,35864,278,1.23 [1.10-1.37],0.0002532689351566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,34892,262,1.63 [1.35-1.96],3.234816810592116e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,41509,324,2.40 [1.87-3.08],6.322449707245753e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,35864,278,1.61 [1.33-1.95],1.1948386251184089e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,34825,269,2.85 [2.03-4.01],1.634215197198724e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,40502,311,1.73 [1.29-2.32],0.0002158039058135
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,41195,324,1.71 [1.28-2.29],0.0003017679307518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,41111,322,1.76 [1.28-2.41],0.0004877451564446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,40301,312,1.81 [1.50-2.19],3.947331253420312e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,35790,277,2.60 [2.02-3.35],1.0535178781247132e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,41247,323,0.50 [0.37-0.68],7.698528245321117e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,41239,323,1.54 [1.21-1.96],0.0004262555211816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,35747,279,2.31 [1.70-3.15],8.625805643195727e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,41390,323,2.38 [1.95-2.90],1.0862673534057977e-17
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,40937,319,3.05 [2.56-3.64],3.9752981693187535e-35
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,41402,323,3.03 [2.18-4.22],3.576739963270715e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,35885,280,1.77 [1.38-2.28],8.58203471015426e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40937,319,1.31 [1.14-1.52],0.0001937569476626
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,34825,269,1.82 [1.38-2.40],1.966851982333125e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,41322,323,1.83 [1.32-2.55],0.0002985890219538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,41239,323,2.32 [1.58-3.39],1.5484979234812977e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,41710,326,1.74 [1.28-2.35],0.0003470053012261
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,41483,321,0.63 [0.49-0.81],0.0003113711205325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,41251,321,1.87 [1.38-2.54],6.268187346918815e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,35497,277,1.30 [1.13-1.49],0.0003199152808898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,41402,323,1.27 [1.12-1.45],0.0003319991969909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,41603,324,1.29 [1.16-1.43],1.393174633883994e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,41603,324,1.71 [1.61-1.81],4.5254287991831554e-73
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,41402,323,1.72 [1.55-1.92],4.661997071027583e-23
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,41239,323,3.28 [2.49-4.32],3.892416620399517e-17
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,40413,318,1.34 [1.15-1.57],0.0002460511454412
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,35697,278,1.47 [1.21-1.80],0.0001311430772824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,41351,323,2.80 [2.07-3.78],1.9489902627371388e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,40468,316,0.52 [0.37-0.74],0.0001960276045826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,40771,321,2.37 [1.86-3.01],1.7503842774937166e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,41045,321,1.94 [1.32-2.83],0.0006464591924633
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,41549,321,2.85 [2.18-3.73],1.7606075092485576e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,41611,321,1.97 [1.54-2.52],6.14324140516202e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,34825,269,1.39 [1.15-1.68],0.0005982212121269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,35707,278,1.67 [1.26-2.21],0.0003321873091019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,41179,320,1.77 [1.27-2.47],0.0007761568039138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,40867,318,3.44 [2.66-4.46],6.599893472288261e-21
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,40301,312,1.57 [1.26-1.96],5.783386831723652e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,41742,327,0.35 [0.19-0.63],0.000521040409515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,41195,324,1.28 [1.12-1.46],0.000357041657677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,39783,312,2.16 [1.69-2.78],1.4158739756058112e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,40861,319,2.56 [1.90-3.45],5.951409030594465e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,41195,324,1.31 [1.18-1.46],7.47765824963588e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,41603,324,2.44 [1.70-3.51],1.439330274622669e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,35859,278,2.26 [1.98-2.59],3.3620849284596725e-33
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,41247,323,2.47 [2.16-2.84],2.025466421647867e-38
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,41239,323,2.90 [2.43-3.45],1.0593596849940768e-32
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,41516,323,3.10 [2.78-3.46],1.438048794490299e-90
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,40496,312,2.28 [1.94-2.68],4.2328946757167325e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,41247,323,1.51 [1.28-1.79],1.5871246081757616e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,41195,324,1.32 [1.14-1.53],0.0001725153511625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,40301,312,1.48 [1.32-1.67],1.6053600674616657e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,41351,323,0.60 [0.45-0.81],0.0007250099449011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,35864,278,0.62 [0.49-0.78],4.813299550742634e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40937,319,1.85 [1.32-2.58],0.000334636266059
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,34908,268,1.42 [1.17-1.71],0.0002728927773503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,34908,268,2.44 [1.56-3.83],9.793759288394168e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,40240,312,1.48 [1.18-1.86],0.0005966842976295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,41402,323,0.73 [0.63-0.85],7.195561504984723e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,41045,321,1.82 [1.29-2.58],0.0006482564761819
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,35725,277,1.54 [1.32-1.80],2.9774742386319922e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,34246,266,1.43 [1.18-1.72],0.0002026669493822
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",41045,321,2.72 [2.11-3.53],2.4650935616118902e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,41742,327,1.62 [1.36-1.93],9.005854706359978e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,41549,321,1.87 [1.33-2.61],0.0002718978242127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,35790,277,1.99 [1.42-2.78],5.434085366797648e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,34995,269,1.47 [1.19-1.82],0.0003281632072526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,41603,324,1.93 [1.37-2.71],0.0001556226040464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,41047,319,2.98 [2.06-4.30],6.162154940907629e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",41045,321,1.32 [1.14-1.53],0.0002829866021895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,41710,326,2.24 [1.81-2.77],1.4200703027499985e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,40502,311,1.24 [1.12-1.38],2.739880514431631e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,41247,323,1.90 [1.46-2.46],1.3770377248662275e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,35548,276,0.63 [0.48-0.83],0.0007416172090896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,35718,275,1.49 [1.26-1.76],2.056098032756893e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",41195,324,2.65 [2.01-3.50],3.845506458239847e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,40734,318,1.49 [1.21-1.83],0.0001450060539152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,35805,276,1.39 [1.16-1.68],0.0004661412235817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,41611,321,1.64 [1.33-2.03],4.74063316275693e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,41064,320,2.24 [1.63-3.07],6.497031988204041e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,41742,327,1.87 [1.37-2.54],8.493826842402974e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,41742,327,5.83 [4.27-7.94],7.459818901403596e-29
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,34852,266,2.34 [1.84-2.98],4.812666044264522e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,41402,323,2.44 [1.66-3.59],5.475441881384064e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,40279,316,1.55 [1.28-1.88],6.775388000481081e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,41195,324,1.96 [1.67-2.30],8.679189386375831e-17
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,35864,278,0.49 [0.34-0.73],0.0003484012120844
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,41673,327,1.48 [1.26-1.74],1.608064806332506e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,40726,320,1.54 [1.25-1.90],4.374454593226372e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,41045,321,1.57 [1.21-2.04],0.0006316635040878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,40496,312,1.46 [1.35-1.57],2.6820494882990924e-23
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,41402,323,1.90 [1.44-2.51],5.954656743848205e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,41045,321,1.77 [1.59-1.98],1.7583393842782273e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,41710,326,2.29 [1.93-2.71],1.414346047543001e-21
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,40496,312,2.30 [1.84-2.88],2.221749292746697e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,40496,312,2.14 [1.62-2.84],1.0549566305428057e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,41710,326,1.42 [1.17-1.73],0.0004947590619629
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,40679,324,1.45 [1.21-1.74],6.733984026172455e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,41062,320,1.76 [1.46-2.12],2.071642424093057e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,41390,323,2.71 [2.07-3.53],2.2256322281513172e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,41710,326,1.74 [1.30-2.32],0.000169800779234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,41179,320,2.24 [1.50-3.34],7.258367463241187e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,40952,322,3.50 [2.96-4.15],4.046417405578913e-48
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,35697,278,1.49 [1.21-1.84],0.0001492239188902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,41195,324,1.49 [1.21-1.83],0.0001362323728534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,40496,312,1.66 [1.24-2.22],0.0007147930007039
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,41195,324,2.11 [1.68-2.65],1.6289493785459027e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,41045,321,1.29 [1.17-1.43],3.825160811710193e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,35697,278,1.56 [1.29-1.88],4.335470102095523e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,34825,269,1.65 [1.24-2.19],0.0005638781748375
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,41000,321,1.75 [1.26-2.44],0.0007972721225502
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,41611,321,1.47 [1.21-1.80],0.000124284722384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,41195,324,1.45 [1.24-1.69],3.7408550915267697e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,40496,312,1.63 [1.40-1.89],2.1740420159987558e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,35105,268,1.62 [1.35-1.95],1.6355174766166962e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,40279,316,1.50 [1.20-1.86],0.0003369384675101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,41710,326,2.22 [1.74-2.82],9.713940285989663e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,41710,326,1.67 [1.36-2.05],1.1791120635926671e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,35790,277,1.79 [1.48-2.18],2.692131624671156e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",41131,324,1.29 [1.12-1.47],0.0003244056481384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,41045,321,2.15 [1.82-2.53],8.533666918952097e-20
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,41202,322,2.02 [1.66-2.47],3.937530987258661e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40937,319,1.28 [1.16-1.42],1.9916569023018263e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,41636,325,1.42 [1.18-1.71],0.000190265217838
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,40861,319,1.75 [1.34-2.28],4.083242955963483e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,41214,321,2.86 [2.17-3.77],8.226044558114037e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,41247,323,1.69 [1.27-2.26],0.000362066303408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,41184,322,2.02 [1.50-2.73],4.683059484821908e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,41742,327,2.73 [1.92-3.89],2.283259605436943e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,41544,326,1.73 [1.29-2.33],0.0002560732837027
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40496,312,2.14 [1.73-2.63],1.2421880176133424e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,35790,277,2.95 [2.23-3.90],2.9673418955159585e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,35912,278,2.92 [2.00-4.27],2.9061699342741723e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,41490,321,2.26 [1.73-2.95],1.6680442220688363e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,41045,321,1.51 [1.22-1.87],0.0001718746070803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,41195,324,1.50 [1.19-1.89],0.0005048779202236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,41195,324,2.24 [1.94-2.58],1.6071351153940014e-28
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,41742,327,2.03 [1.51-2.73],2.6059252575048727e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,41007,321,2.14 [1.56-2.94],2.1962265018033707e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,41195,324,1.73 [1.33-2.26],5.181825613737072e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,40789,319,6.45 [4.89-8.53],2.429523748914641e-39
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,40301,312,1.48 [1.30-1.68],1.409592056590183e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40795,318,1.47 [1.29-1.67],1.1116032054120376e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",34908,268,2.94 [1.86-4.66],4.096542090862239e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,41239,323,3.06 [2.12-4.43],2.5903892802076086e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,41274,322,1.83 [1.31-2.54],0.0003621486871301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,40496,312,1.49 [1.23-1.80],3.451186506501602e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,41301,321,1.58 [1.33-1.88],2.022132783135317e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,41247,323,1.44 [1.20-1.73],9.362006333990724e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,41335,323,1.38 [1.15-1.66],0.0005862112249954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,35707,278,1.79 [1.30-2.47],0.0003349367398243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,41184,322,2.07 [1.52-2.81],3.30658730860094e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,40301,312,1.52 [1.27-1.83],8.242532255845037e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,34246,269,2.42 [1.65-3.55],6.585581318590386e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",40279,316,1.47 [1.24-1.74],6.66276358754834e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",40279,316,2.02 [1.86-2.20],4.439624848230509e-62
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,41742,327,3.79 [2.09-6.87],1.1168300710152592e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,35262,272,2.21 [1.72-2.85],8.261738059793903e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,41239,323,1.67 [1.26-2.22],0.00034530915708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,41195,324,1.47 [1.22-1.78],5.2433789831866296e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,41239,323,2.03 [1.46-2.82],2.2826345405490794e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,41247,323,1.86 [1.36-2.54],9.40815450632346e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,41239,323,1.17 [1.07-1.28],0.0003375788310986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,35805,276,1.61 [1.28-2.04],6.825880034200072e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,35197,269,1.28 [1.12-1.47],0.0003214201997265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,41045,321,1.76 [1.32-2.34],0.0001308195739268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,35783,278,3.65 [2.21-6.05],4.884516220956779e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,41274,322,2.24 [1.67-3.00],5.97228878946626e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,41195,324,1.28 [1.13-1.45],9.164669976977692e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,41239,323,1.63 [1.25-2.12],0.0003018341450464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,41545,319,3.80 [3.44-4.19],4.795987625551616e-158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,41045,321,1.87 [1.39-2.52],3.3620456648364745e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,41710,326,2.30 [1.79-2.95],8.552452284437189e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,34892,262,1.29 [1.13-1.49],0.0002848827103421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,41247,323,2.17 [1.58-2.98],1.873139867969103e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,40945,320,2.50 [1.78-3.50],1.0590233605399548e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,41557,326,1.96 [1.32-2.89],0.0007480570453902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,34825,269,1.46 [1.19-1.80],0.0003084496362554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",41045,321,1.60 [1.31-1.94],2.7675364636298745e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,40192,316,1.42 [1.21-1.68],3.106736884187053e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,35532,274,2.08 [1.55-2.77],7.655879952354829e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,40931,319,1.99 [1.51-2.62],1.0200424021275003e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,35864,278,5.55 [3.86-7.99],2.3786491926108635e-20
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,41294,323,2.27 [1.61-3.21],3.1904121478770087e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,40301,312,1.26 [1.10-1.45],0.0009080822625382
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,35805,276,1.68 [1.34-2.11],6.545427768597086e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,41045,321,1.46 [1.24-1.71],3.890423461133721e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,35697,278,1.39 [1.18-1.62],5.157473579114178e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,40991,319,1.39 [1.17-1.67],0.0002612269730927
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,41742,327,1.35 [1.18-1.56],2.6390199412668845e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,41247,323,2.67 [1.98-3.60],1.2311620191223635e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,35622,279,1.78 [1.46-2.18],2.2914196339213745e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,41555,325,2.67 [2.06-3.45],1.0545160685217161e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,34908,268,2.45 [1.93-3.13],4.0272848383295444e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,41274,322,3.36 [2.39-4.73],3.772671803076345e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,34908,268,1.57 [1.26-1.97],7.797272837115194e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,40301,312,1.56 [1.40-1.75],4.163733372153909e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,40158,312,2.21 [1.67-2.92],2.4244964754538298e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,41239,323,1.74 [1.40-2.16],5.744750344202377e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,35096,275,1.80 [1.43-2.27],8.055009743226718e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,34908,268,1.54 [1.23-1.93],0.0001559354147913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,35912,278,3.83 [2.60-5.65],1.1823492126648626e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,35096,275,1.79 [1.43-2.24],4.49991963880448e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,41603,324,2.23 [1.60-3.10],1.980084463086266e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,41613,326,3.99 [3.27-4.86],1.0631101291894186e-42
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,35717,277,1.71 [1.26-2.32],0.0005254560853361
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,35369,274,0.49 [0.32-0.75],0.0008726643080232
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,40835,320,1.83 [1.63-2.06],3.953868619659148e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,41710,326,1.31 [1.16-1.49],2.0779922076078945e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,41195,324,1.34 [1.18-1.53],1.0026330193479043e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,35864,278,2.39 [1.80-3.17],1.4769939413878702e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,41402,323,1.68 [1.34-2.09],5.199799062529284e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,41195,324,5.31 [4.24-6.64],2.029353583578285e-48
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,41611,321,3.24 [2.63-3.99],1.1252606028236284e-28
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,34908,268,1.96 [1.53-2.52],1.4140315077769536e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,41134,322,1.94 [1.58-2.38],1.8218179591809008e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,40496,312,1.38 [1.16-1.64],0.0003080609177845
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,40301,312,2.57 [2.10-3.13],1.4342942255721132e-20
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,40301,312,2.14 [1.79-2.56],6.846447909164135e-17
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,41611,321,1.61 [1.26-2.06],0.0001709051555287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,35707,278,1.29 [1.13-1.49],0.0002956874035086
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',35790,277,1.36 [1.17-1.59],7.442817241377914e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,40301,312,1.77 [1.34-2.33],5.152669939721773e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,41247,323,1.50 [1.20-1.86],0.0002642930945123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,35096,275,1.68 [1.26-2.24],0.0004049898330805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,41195,324,1.30 [1.13-1.50],0.0002336170526909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,41113,319,2.08 [1.46-2.97],4.830595011380949e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,41603,324,1.97 [1.63-2.38],4.058900947321648e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,35707,278,1.88 [1.55-2.29],1.7008809457466802e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,35859,278,2.39 [1.97-2.89],4.4449364925576565e-19
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,35697,278,1.26 [1.11-1.43],0.0002752887585746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,41351,323,1.68 [1.28-2.22],0.0002140092165597
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,41239,323,2.01 [1.49-2.71],4.95915079478802e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",40203,316,1.41 [1.17-1.70],0.0003545441258714
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,35197,269,1.89 [1.68-2.13],1.7438188390631187e-25
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,41390,323,1.49 [1.20-1.86],0.0003986079721644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,41113,321,2.39 [1.55-3.70],8.739769653055356e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",35197,269,1.49 [1.23-1.80],4.388079739378252e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,41390,323,1.65 [1.36-2.01],5.74556861356388e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,40436,311,1.86 [1.66-2.09],9.462990973007848e-26
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40937,319,2.17 [1.78-2.64],1.8482415781748284e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40937,319,1.43 [1.29-1.58],1.3195329337697776e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41710,326,1.69 [1.33-2.14],1.4221864206330795e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,41274,322,3.94 [3.47-4.46],5.931044829764776e-101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40496,312,3.52 [3.14-3.95],3.4824741546001107e-102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,41274,322,2.17 [1.62-2.91],2.491195596099944e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,35096,275,2.77 [2.12-3.61],5.375717256820691e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,41611,321,1.79 [1.35-2.39],5.7993397736026574e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,41247,323,2.16 [1.61-2.90],2.618280076332732e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,41247,323,1.78 [1.57-2.03],8.151365490193064e-19
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,41636,325,5.02 [4.22-5.96],2.9991121712848677e-75
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40937,319,1.67 [1.46-1.92],2.796397056023849e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,41603,324,2.91 [2.52-3.36],3.3072292931795977e-48
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40937,319,4.11 [3.72-4.54],1.6999937253891992e-172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,41195,324,1.40 [1.19-1.64],4.257185266696743e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,35864,278,3.08 [2.45-3.86],3.3354225646276174e-22
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,35859,278,2.29 [1.54-3.42],4.858847495676648e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,34731,268,1.36 [1.16-1.59],0.0001557722835173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,41247,323,2.12 [1.60-2.81],1.5468545183569716e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,40937,319,1.85 [1.46-2.35],4.756011159816937e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,35790,277,1.50 [1.20-1.88],0.0004482129628029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,41330,322,4.91 [3.69-6.54],1.2120656913623176e-27
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,35697,278,1.38 [1.17-1.62],0.0001253940547288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,41192,323,1.75 [1.40-2.20],1.1495180539115704e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",41247,323,1.62 [1.26-2.09],0.0002091373885051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,39127,303,1.88 [1.50-2.36],4.170599916395127e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,41611,321,1.42 [1.24-1.63],4.242460975309914e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,34825,269,1.75 [1.46-2.10],1.8829416975094678e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,40502,311,1.59 [1.35-1.88],3.485946988557691e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,35790,277,1.74 [1.45-2.08],2.1402351713970318e-09
